Fiscal impact reports (FIRs) are prepared by the Legislative Finance Committee (LFC) for standing finance
committees of the NM Legislature. The LFC does not assume responsibility for the accuracy of these reports
if they are used for other purposes.
Current FIRs (in HTML & Adobe PDF formats) are a vailable on the NM Legislative Website (legis.state.nm.us).
Adobe PDF versions include all attachments, whereas HTML versions may not. Previously issued FIRs and
attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North.
F I S C A L I M P A C T R E P O R T
SPONSOR Begaye
ORIGINAL DATE
LAST UPDATED
02/04/08
HB 621
SHORT TITLE Promote Subatomic Beams for Cancer Treatment
SB
ANALYST Escudero
APPROPRIATION (dollars in thousands)
Appropriation
Recurring
or Non-Rec
Fund
Affected
FY08
FY09
$10.0
Recurring
General Fund
(Parenthesis ( ) Indicate Expenditure Decreases)
Relates to HB35, HB98, HB381, HB394, HB536, SB178, SB199, SB244
SOURCES OF INFORMATION
LFC Files
Responses Received From
Human Services Department (HSD)
Department of Health (DOH)
No Response Received From
Higher Education Department (HED)
University of New Mexico (UNM)
SUMMARY
Synopsis of Bill
House Bill 621 is an appropriation from the general fund to the Human Services Department for
expenditure in fiscal year 2009 to promote scientific research and technological advances in the
treatment of certain cancers using subatomic particle beams.
FISCAL IMPLICATIONS
The appropriation of $10.0 contained in this bill is a recurring expense to the general fund. Any
unexpended or unencumbered balance remaining at the end of FY09 shall revert to the general
fund
The money cannot be matched with federal Medicaid matching funds from CMS because the
treatment is research, investigational medical use, and promotion.
pg_0002
House Bill 621 – Page
2
SIGNIFICANT ISSUES
According to DOH, radiation therapy is the use of a certain type of energy to kill cancer cells and
shrink tumors, and is used to treat many different types of cancer. The radiation treatment
method used depends on a number of factors, including the type of cancer and whether there are
tissues and organs nearby that may be damaged by radiation. Particle beam radiation therapy is a
treatment that uses fast-moving subatomic particles. Particle beams are created by
linear
accelerators
, synchrotrons, and cyclotrons, which produce and accelerate the particles required
for this type of radiation therapy. Particle beam therapy uses electrons, which are produced by
an x-ray tube (this may be called electron-beam radiation); neutrons, which are produced by
radioactive elements and special equipment; heavy ions (such as
protons
and helium); and pi-
mesons (also called pions), which are small, negatively charged particles produced by an
accelerator and a system of magnets. Unlike x-rays and gamma rays, some particle beams can
penetrate only a short distance into tissue. Therefore, they are often used to treat cancers located
on the surface of or just below the skin.
DOH further notes, proton beam therapy is a type of particle beam radiation therapy. High doses
of proton beam therapy can be targeted to a tumor while doing less damage to normal tissues in
front of and behind the tumor. Proton beam therapy is available at only a few facilities in the
United States. Its use is generally reserved for cancers that are difficult or dangerous to treat
with surgery (such as a
chondrosarcoma
at the base of the skull), or it is combined with other
types of radiation. Proton beam therapy is also being used in clinical trials for
intraocular
melanoma
(
melanoma
that begins in the eye),
retinoblastoma
(an eye cancer that most often
occurs in children under age 5),
rhabdomyosarcoma
(a tumor of the muscle tissue), some cancers
of the head and neck, and cancers of the prostate, brain, and lung.
The $10,000 appropriation proposed in HB621 may not be a large enough appropriation to
promote meaningful scientific research or technological advances in this highly technical field.
As stated by HSD, the department is a large purchaser of health care but generally has no role in
developing new medical technology or administering grants to do so. Also, HSD would not be
in a position to evaluate any product from the expenditure.
It would be more appropriate for the money to be given to the Department of Health (DOH) to
award as a grant, to the UNM School of Medicine, or to the UNM Hospital Cancer Treatment
Center. DOH administers the tumor registry and the UNM entities are noted for cancer research
and treatment.
DUPLICATION, CONFLICT, COMPANIONSHIP OR RELATIONSHIP
HB621 relates to:
HB35, which would appropriate $500,000 from the General Fund to DOH to fund screening
and treatment of breast and cervical cancer;
HB98, which would appropriate $25,000 from the General Fund to DOH to provide for
volunteer-led clinics to help cancer patients or caregivers navigate legal, insurance and
paperwork issues, and to supply cancer patients or caregivers with a cancer treatment
organizer tool;
HB381, which would enact a newly created section to the New Mexico Drug, Device and
Cosmetic Act to allow for unused and unadulterated prescription cancer medications to be
pg_0003
House Bill 621 – Page
3
donated by a cancer patient or the patient’s family to a healthcare facility or to a pharmacy
that elects to participate in the program;
HB394, which would appropriate $1.3 million for expenditure in FY09 from the Tobacco
Settlement Program fund to Veterans’ Services Department to contract with an organization
to provide validation of diagnostic technology for the early detection of lung cancer;
HB536, which would appropriate $60,000 to DOH from the General Fund in FY09 to
provide services to indigent cancer patients in Chaves, Eddy, Lea and Lincoln counties;
SB178, which would create a new license plate promoting awareness and providing a
funding source for breast cancer research and education;
SB199, which would appropriate $1,500,000 to DOH to develop and implement a statewide
voucher program to provide baseline mammograms to women in low-income households;
and
SB244, which would provide for parents or guardians of female students ages nine to
fourteen years of age to receive educational information about cervical cancer and the human
papillomavirus vaccine.
PME/jp